Literature DB >> 16378012

Visual evoked potentials of the blue-sensitive pathway under cold provocation in normals and glaucomas.

Folkert K Horn1, Georg Michelson, Eckbert Schnitzler, Christian Y Mardin, Matthias Korth, Anselm G Jünemann.   

Abstract

BACKGROUND: Vascular dysregulation in open-angle glaucomas can be identified by measuring the blood circulation during exposure to cold water. Aim of this study was to find out whether the same cold stimulus would lead to functional changes in the visual evoked potentials (VEP) of the short-sensitive pathway in normals and glaucoma patients. PATIENTS AND METHODS: Blue-on-yellow pattern-visual evoked potentials were studied in 22 healthy control persons and 47 patients with primary open-angle glaucoma (25 high-pressure glaucomas, 22 normal pressure glaucomas with clinical signs of vasospastic hyperreactivity). A blue stripe pattern, presented in onset-offset mode on a yellow adaptation light served as the stimulus. Cold provocation was initiated by dipping one hand of the patient into cold water of 3 degrees C to 5 degrees C. The onset amplitudes and peak times were measured without cold exposition as well as two and four minutes after the cold exposition began.
RESULTS: In the group of vasospastic glaucoma patients a significant reduction of visual evoked potential-amplitudes was observed during cold provocation (amplitude before ice exposition: 4.17 microV, amplitude following two minutes of ice exposition: 3.52 microV; paired test: P < 0.01). Other subject groups showed no significant amplitude reductions after cold provocation. Peak times of both open-angle glaucoma groups (132.3 +/- 18.7 milliseconds in high pressure, 132.7 +/- 14.5 milliseconds in normal pressure) were significantly increased in comparison to normals (117.4 +/- 8.0 milliseconds). However, no significant influence of the cold provocation on peak times could be found in all groups.
CONCLUSION: Peak times of the blue-on-yellow visual evoked potentials are significantly prolonged in patients with primary open-angle glaucomas. Cold provocation causes a significant amplitude reduction of the blue-on-yellow visual evoked potential in the present normal-pressure glaucoma patients and reflects vascular dysregulation in patients with vasospastic hyperreactivity.

Entities:  

Mesh:

Year:  2006        PMID: 16378012     DOI: 10.1097/01.ijg.0000196656.23578.1b

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  6 in total

1.  [Flicker provocation with LED full-field stimulation in normals and glaucoma patients].

Authors:  F K Horn; B Link; K Dehne; R Lämmer; A G Jünemann
Journal:  Ophthalmologe       Date:  2006-10       Impact factor: 1.059

2.  [Recovery time as a potential new progression parameter for patients with advanced glaucomatous optic atrophy].

Authors:  B Hohberger; S Mißlinger; F Horn; J Kremers
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

3.  Blue-yellow and standard pattern visual evoked potentials in phakic and pseudophakic glaucoma patients and controls.

Authors:  Matthias Fuest; Jule Kieckhoefel; Babac Mazinani; David Kuerten; Antonis Koutsonas; Eva Koch; Peter Walter; Niklas Plange
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-04       Impact factor: 3.117

4.  Visual impairment in an optineurin mouse model of primary open-angle glaucoma.

Authors:  Henry C Tseng; Thorfinn T Riday; Celia McKee; Catherine E Braine; Howard Bomze; Ian Barak; Carrie Marean-Reardon; Simon W M John; Benjamin D Philpot; Michael D Ehlers
Journal:  Neurobiol Aging       Date:  2015-02-27       Impact factor: 4.673

5.  Transient visual field impairment after cold provocation in glaucoma patients with Flammer syndrome.

Authors:  Barbara Terelak-Borys; Iwona Grabska-Liberek; Andreas Schoetzau; Katarzyna Konieczka
Journal:  Restor Neurol Neurosci       Date:  2019       Impact factor: 2.406

6.  Blue-Yellow VEP with Projector-Stimulation in Glaucoma.

Authors:  Laura Dussan Molinos; Cord Huchzermeyer; Robert Lämmer; Jan Kremers; Folkert K Horn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-25       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.